Apyx Medical Q4 GAAP EPS $(0.28) May Not Be Comparable To $(0.18) Estimate, Sales $14.66M Miss $14.85M Estimate
Apyx Medical Q4 GAAP EPS $(0.28) May Not Be Comparable To $(0.18) Estimate, Sales $14.66M Miss $14.85M Estimate
Apyx Medical第四季度GAAP每股收益美元（0.28美元）可能無法與預期的美元（0.18美元）相提並論，銷售額爲1466萬美元未達到1485萬美元的預期
Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.18) by 55.56 percent. This is a 64.71 percent decrease over losses of $(0.17) per share from the same period last year. The company reported quarterly sales of $14.66 million which missed the analyst consensus estimate of $14.85 million by 1.27 percent. This is a 16.26 percent increase over sales of $12.61 million the same period last year.
Apyx Medical（納斯達克股票代碼：APYX）公佈的季度虧損爲每股0.28美元，比分析師普遍預期的0.18美元（0.18美元）低55.56％。這比去年同期每股虧損0.17美元（0.17美元）下降了64.71％。該公司公佈的季度銷售額爲1466萬美元，比分析師普遍預期的1485萬美元低1.27％。這比去年同期的1,261萬美元的銷售額增長了16.26％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。